Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Kimberly C Banks"'
Autor:
David E Piccioni, Achal Singh Achrol, Lesli A Kiedrowski, Kimberly C Banks, Najee Boucher, Garni Barkhoudarian, Daniel F Kelly, Tiffany Juarez, Richard B Lanman, Victoria M Raymond, Minhdan Nguyen, Judy D Truong, Annie Heng, Jaya Gill, Marlon Saria, Sandeep C Pingle, Santosh Kesari
Publikováno v:
CNS Oncology, Vol 8, Iss 2 (2019)
Aim: Genomically matched trials in primary brain tumors (PBTs) require recent tumor sequencing. We evaluated whether circulating tumor DNA (ctDNA) could facilitate genomic interrogation in these patients. Methods: Data from 419 PBT patients tested cl
Externí odkaz:
https://doaj.org/article/ef6262da7ada4d6092de61d74bc2de20
Autor:
James T. Topham, Chris J. O'Callaghan, Harriet Feilotter, Hagen F. Kennecke, Young S. Lee, Weimin Li, Kimberly C. Banks, Katie Quinn, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree
Publikováno v:
Journal of Clinical Oncology. 41:485-496
PURPOSE Anti–epidermal growth factor receptor (EGFR) antibodies are effective treatments for metastatic colorectal cancer. Improved understanding of acquired resistance mechanisms may facilitate circulating tumor DNA (ctDNA) monitoring, anti-EGFR r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22964a740c3d56ce5dca924161092557
https://doi.org/10.1200/jco.22.00364
https://doi.org/10.1200/jco.22.00364
Autor:
Jeeyun Lee, Aleksandra Franovic, Yukimasa Shiotsu, Seung Tae Kim, Kyoung-Mee Kim, Kimberly C. Banks, Victoria M. Raymond, Richard B. Lanman
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: HER2 antagonists have marked activity and are approved for the treatment of HER2 overexpressing breast and gastric cancers. Recent studies have shown that ERBB2 (HER2) gene amplification and overexpression may also be actionable in other
Externí odkaz:
https://doaj.org/article/9d77b0f9e0ba4618b2c746f3664aef09
Autor:
Scott Kopetz, Ryan B. Corcoran, Igor F. Tsigelny, AmirAli Talasaz, Richard B. Lanman, Funda Meric-Bernstam, Rebecca J. Nagy, Kimberly C. Banks, Chloe E. Atreya, W. Michael Korn, Matthew McKinney, Allan Andresson Lima Pereira, Donna Niedzwiecki, Aparna R. Parikh, Leanne G. Ahronian, Jonathan M. Loree, John H. Strickler
Suppementary Table S1: Gene lists and exon coverage; Supplementary Table S2: Patient Demographics; Supplementary Table S3. Mutational landscape in cfDNA; Supplementary Figure S1: Schema for identification of unique patient cases for analysis; Supplem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ff65abf18dba7fd0e6b3f47d18b7a3d
https://doi.org/10.1158/2159-8290.22532036.v1
https://doi.org/10.1158/2159-8290.22532036.v1
Autor:
AmirAli Talasaz, Richard B. Lanman, Darya I. Chudova, Helmy Eltoukhy, Arthur M. Baca, Rebecca J. Nagy, Justin I. Odegaard, Philip C. Mack, David R. Gandara, Reza Mokhtari, James V. Vowles, Stefanie A. Mortimer, Stephen R. Fairclough, Kimberly C. Banks, Oliver A. Zill
Driver alteration prevalence in the cfDNA cohort versus in TCGA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a00368eed83a7ebaf7ef55aeadce0a6
https://doi.org/10.1158/1078-0432.22470284.v1
https://doi.org/10.1158/1078-0432.22470284.v1
Autor:
Rajiv Raja, Vikram K. Chand, Kimberly C. Banks, Brandon W. Higgs, Koustubh Ranade, Philip Z. Brohawn, Naiyer A. Rizvi, Solange Peters, Urban Scheuring, Feng Liu, Jiabu Ye, Elena Helman, Katie J. Quinn, Michael Kuziora, Han Si
Patient-level clinical outcome data (overall survival) and bTMB scores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53066b9fcbf2f03413b7a491cc030a7b
https://doi.org/10.1158/1078-0432.22481486
https://doi.org/10.1158/1078-0432.22481486
Autor:
AmirAli Talasaz, Darya I. Chudova, Richard B. Lanman, Helmy Eltoukhy, Cloud P. Paweletz, Lesli A. Kiedrowski, Christine E. Lee, Rebecca J. Nagy, Diana Abdueva, Reza Mokhtari, Marcin Sikora, Oliver A. Zill, Stephen R. Fairclough, Kimberly C. Banks, Bryan C. Ulrich, James V. Vowles, Stefanie Mortimer, John J. Vincent, Justin I. Odegaard
Quantitative precision of Digital Sequencing results. (a) SNV VAFs in 375 consecutive SNV control runs. (b) Indel and fusion VAFs (left y-axis) and CNA copy number (right y-axis) in consecutive CFI control runs. (c) Variation distribution of DS resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d155292ad560e81f025fe35673583cd
https://doi.org/10.1158/1078-0432.22469976.v1
https://doi.org/10.1158/1078-0432.22469976.v1
Autor:
AmirAli Talasaz, Darya I. Chudova, Richard B. Lanman, Helmy Eltoukhy, Cloud P. Paweletz, Lesli A. Kiedrowski, Christine E. Lee, Rebecca J. Nagy, Diana Abdueva, Reza Mokhtari, Marcin Sikora, Oliver A. Zill, Stephen R. Fairclough, Kimberly C. Banks, Bryan C. Ulrich, James V. Vowles, Stefanie Mortimer, John J. Vincent, Justin I. Odegaard
Detailed results of Digital Sequencing and clinical ddPCR comparison. Results shown in individual 2x2 tables for each biomarker tested. *Note, all discordances were below DFCI ddPCR's reportable range. Detailed clinical information for each is presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511920faa735b65604cb11ca6d9f8ea4
https://doi.org/10.1158/1078-0432.22469967.v1
https://doi.org/10.1158/1078-0432.22469967.v1
Autor:
Robert C. Doebele, Alice T. Shaw, Richard B. Lanman, Kurtis D. Davies, Dara L. Aisner, William T. Purcell, Saiama N. Waqar, Joseph Diaz, Christine E. Lee, Anh T. Le, Victoria M. Raymond, Ben M. Chue, Benjamin Levy, Kimberly C. Banks, Collin M. Blakely, Caroline E. McCoach
Supplementary Figures 1,2, 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f38d61c5fa2e8747122d6aec6577ff
https://doi.org/10.1158/1078-0432.22464351
https://doi.org/10.1158/1078-0432.22464351
Autor:
Razelle Kurzrock, Sadakatsu Ikeda, Funda Meric-Bernstam, James C. Yao, Robert A. Wolff, Kanwal P.S. Raghav, Abedul Haque, Bhawana George, Kenna R. Mills-Shaw, AmirAli Talasaz, Richard B. Lanman, Kimberly C. Banks, Asif Rashid, Manal M. Hassan, Hesham M. Amin, Jeffrey Morris, Lianchun Xiao, Wei Qiao, Roberto Carmagnani Pestana, Marc Uemura, Reham Abdel-Wahab, Kian H. Lim, Andrea G. Bocobo, Benjamin Tan, Robin K. Kelley, Shiraj Sen, Nora S. Sánchez, Ahmed O. Kaseb
Purpose:Molecular profiling has been used to select patients for targeted therapy and determine prognosis. Noninvasive strategies are critical to hepatocellular carcinoma (HCC) given the challenge of obtaining liver tissue biopsies.Experimental Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc7bcc4a5c85785aef33cebdc420dad
https://doi.org/10.1158/1078-0432.c.6527795.v1
https://doi.org/10.1158/1078-0432.c.6527795.v1